ÂÜÀòÂÒÂ×

Brad Donahue, CPA, currently serves as Associate Director of Financial Planning and Analysis (FP&A) at ImmunoGen, Inc., a position held since April 2022, after advancing from Senior Manager of FP&A. Prior experience includes a managerial role in FP&A at CRISPR Therapeutics and multiple management positions at Deloitte, focusing on mergers, acquisitions, and divestitures within the life science and healthcare sectors. Earlier career highlights include assurance roles at EY and various accounting positions at Vertex Pharmaceuticals and Bauer Hockey. Brad Donahue earned a Bachelor of Business Administration (B.B.A.) in Accounting from the University of Massachusetts at Amherst's Isenberg School of Management from 2011 to 2015.